Nicholas Company’s Bristol-Myers Squibb BMY Stock Holding History

Nicholas Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-576,840	Closed	-$34.1M	–	231
2021 Q3	$34.1M	Sell	576,840 -165	-0%	-$10.9K	0.6%	58
2021 Q2	$38.6M	Buy	577,005 +40,340	+8%	+$2.63M	0.68%	57
2021 Q1	$33.9M	Hold	536,665	–	–	0.63%	54
2020 Q4	$33.3M	Buy	536,665 +25,085	+5%	+$1.54M	0.63%	56
2020 Q3	$30.8M	Buy	511,580 +40,045	+8%	+$2.41M	0.65%	56
2020 Q2	$27.7M	Buy	471,535 +200,685	+74%	+$12M	0.64%	57
2020 Q1	$15.1M	Sell	270,850 -20	-0%	-$1.22K	0.43%	66
2019 Q4	$17.4M	Buy	+270,870	New	+$15.5M	0.37%	82
2019 Q2	–	Sell	-300	Closed	-$14K	–	221
2019 Q1	$14K	Hold	300	–	–	﹤0.01%	218
2018 Q4	$15K	Sell	300 -44,810	-99%	-$2.41M	﹤0.01%	225
2018 Q3	$2.8M	Buy	+45,110	New	+$2.68M	0.06%	216

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nicholas Company's BMY Position: Q4 2021 in Review

Nicholas Company sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 576,840 shares — an estimated $34.1M sold.

Nicholas Company first reported a position in BMY in Q3 2018 and held it in 11 quarters. The position peaked at $38.6M in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Nicholas Company reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Nicholas Company sold 576,840 Bristol-Myers Squibb shares in Q4 2021, an estimated $34.1M.
Nicholas Company first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 11 quarters.
Nicholas Company's Bristol-Myers Squibb position peaked at $38.6M in Q2 2021.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Nicholas Company's 13F filing for Q4 2021, filed 11 Feb 2022.